RFA-GH-24-033: Advancing Public Health Research in Bangladesh
Closed
This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2023.
Centers for Disease Control and Prevention - ERA offered grants of up to $6.0 million to the applicants described in the notice. It expected to make one award worth $22.0 million in total. Applications closed on March 8, 2024.
From the official notice on Grants.gov, last changed December 14, 2023. Checked November 7, 2026.
- Award ceiling$6.0 million
- Total funding$22.0 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | December 14, 2023 |
|---|---|
| Deadline | March 8, 2024 |
| Archived by Grants.gov | April 7, 2024 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
icddr,b (formally International Centre for Diarrhoeal Disease Research, Bangladesh) is the sole eligible applicant.
Is this a realistic fit?
- Past Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention awards averaged $1.7 million; this notice allows up to $6.0 million per award.
- Most of the program's money (51% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The purpose of this notice of funding opportunity is to further strengthen the ability of the Government of Bangladesh and other global partners to detect, prevent, and respond to disease threats through high quality public health research and surveillance activities. Specifically, the individual activities under this cooperative agreement will: a) determine burden, trends, etiology, and risk factors of priority diseases in Bangladesh, b) develop and evaluate interventions and diagnostics, c) evaluate the effectiveness of vaccinations to inform global policy, and d) strengthen the Government of Bangladesh’s surveillance, laboratory and outbreak response capacity.
Who has won Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention grants before
From fiscal 2021 to 2025, Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention (93.326) awarded $345 million across 205 grant awards, an average of $1.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Washington State University | Washington | 2 | $23.2 million |
| Association of Public Health Laboratories, Inc. (the) | Maryland | 2 | $19.6 million |
| International Centre for Diarrhoeal Disease Research, Bangladesh | 2 | $13.3 million | |
| Liverpool School of Tropical Medicine | 1 | $10.6 million | |
| California Department of Public Health | California | 1 | $10.3 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-GH-24-033 still open?
No. It closed on March 8, 2024. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.
Who can apply for Advancing Public Health Research in Bangladesh?
Centers for Disease Control and Prevention - ERA accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Advancing Public Health Research in Bangladesh?
Closed March 8, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $6.0 million each. About $22.0 million in total for one award.
Who has won Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention grants before?
The largest recipients over five fiscal years were Washington State University, Association of Public Health Laboratories, Inc. (the), International Centre for Diarrhoeal Disease Research, Bangladesh. The program made 205 awards worth $345 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)